How many insider trades does FilingIQ track for ELTX?

FilingIQ tracks 18 Form 4 insider transactions for ELTX (Elicio Therapeutics, Inc.), covering filings from Dec 22, 2023 onwards. 4 of those were filed in the last 90 days.

Are ELTX insiders net buyers or net sellers?

Across the full Form 4 history for ELTX, 1 transactions (6%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ELTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ELTX in?

Elicio Therapeutics, Inc. (ELTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $150.32M.

ELTX insider trading

Healthcare

Elicio Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

6% / 0%

Market cap

$150.32M

About Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph nodetargeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph nodetargeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph nodetargeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Company website: elicio.com

ELTX insider activity at a glance

FilingIQ has scored 18 insider transactions for ELTX since Dec 22, 2023. The most recent filing in our index is dated Jul 16, 2026.

Across the full history, 1 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ELTX insider trades is 61.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ELTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,070

UNITED THERAPEUTICS Corp

APLS 272

Apellis Pharmaceuticals, Inc.

NUVL 218

Nuvalent, Inc.

KYMR 215

Kymera Therapeutics, Inc.

HNGE 194

Hinge Health, Inc.

GH 189

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for ELTX?: FilingIQ tracks 18 Form 4 insider transactions for ELTX (Elicio Therapeutics, Inc.), covering filings from Dec 22, 2023 onwards. 4 of those were filed in the last 90 days.
Are ELTX insiders net buyers or net sellers?: Across the full Form 4 history for ELTX, 1 transactions (6%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ELTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ELTX in?: Elicio Therapeutics, Inc. (ELTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $150.32M.

Methodology & sources

Every ELTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.